Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, here's a twist. An attorney is already on another board that's going to subpoena email records, phone calls and all other information from attorney Kevin Schall with regards to the CYDY investigation. I'd say this attorney must be an investor or a hired gun. This is going to get interesting to say the least
LAUGHING!
Does anyone know what a nominal defendant is? That means Naders name is on there but means squat. Keep trying! LOL
Absolutely correct sir!
I took it upon myself to call the AG's office regarding the investigation and surprise! YOU"RE CORRECT! It's a typical move used by shorts. In any event, i was lucky and SO FORTUNATE that they will look into this for me and follow up, sounds very bogus to me.
Why should he register? Do the research and you'll find he doesn't need too. Cytodyn is winning!
You think so? Question for you:
If the trial was sub standard or questionable, why didn't the FDA stop it?
Why did the DSMC have Cytodyn continue without modifications?
Why are they washing the numbers and putting it into English now? Would they ( Cytodyn)spend the money to have that done?
Why are so many doctors begging for Leronlimab? ( Before you say anything, I personally know three doctors who are in clinical trial sites that have contacted the FDA to praise how well Leronlimab works)
The SP rise today is based on what? Oh I'll answer this one, INSIDER BUYING, look at the numbers.
One last question, which hedge fund posted on this board asking for opinions?
Looks and smells like victory to me. Looks like triple digits here we come. Looks like Nasdaq here we come!
Clarify what he said- why are you laughing? He said when it was at 30 cents, i wouldnt laugh at that, it's way up from there correct? We'll see triple digits very soon despite the negativity on this board. all in my opinon
Question- if the data was not good, would they still allowed it to be scrubbed and analyzed?
Funny, I heard otherwise. FDA says we're in great shape, we'll see who gets duped, soon, really soon. Cytodyn is going right to the top of the covid treatments available
Off of facebook- poster is legit Dr in North Carolina.
"Fauci mentioned Cytodyn at the Precision World Medicine Conference. Anyone got a link to it?"
Dr. Sanjay Gupta listed on here as an investor
https://www.cytodyn.com/investors/sec-filings/all-sec-filings/content/0001193125-16-448171/d66206ds1.htm?TB_iframe=true&height=auto&width=auto&preload=false
Dr. Gupta is a huge investor in Cytodyn, he knows about it
I guess they know something we don't know! Looks like we're well on our way !
The active ingredient Leronlimab from CytoDyn is a CCR5 antagonist, it blocks a receptor on the surface of certain immune cells. In a phase II trial, it was shown to improve the health of mild to moderate Covid-19 patients. The manufacturer then conducted a Phase III trial in patients with severe disease and applied to the FDA for emergency use approval. Until a decision is made, new patients with severe symptoms at the hospitals that participated in the trial can be treated with Leronlimab. The company is also testing whether Leronlimab will improve late symptoms in Covid 19 patients who have had the infection for a long time. The antibody Leronlimab has long been developed for the treatment of HIV and triple-negative breast cancer, for which it is already being tested in trials. However, its efficacy against HIV is not based on attenuating immunomodulation, but on the fact that the active substance prevents the AIDS viruses from gaining access to the immune cells that they would otherwise infect
Article below:
https://www.vfa.de/de/englische-inhalte/therapeutic-medicines-coronavirus-covid-19
Leronlimab showed non-clinical effect for metastatic triple negative breast cancer:”Herein, leronlimab was shown to bind CCR5 in multiple breast cancer cell lines. Binding of leronlimab to CCR5 reduced ligand-induced Ca+?2 signaling, invasion of TNBC into Matrigel, and transwell migration. Leronlimab enhanced the BCa cell killing of the BCa chemotherapy reagent, doxorubicin. In xenografts conducted with Nu/Nu mice, leronlimab reduced lung metastasis of the TNBC cell line, MB-MDA-231, by >?98% at 6?weeks. Treatment with leronlimab reduced the metastatic tumor burden of established TNBC lung metastasis.”
Credit to Dr. Ross off another board- This is true Due Diligence and knowledge!!
I would like to share some statistics with you that have a bearing on the likely outcome of the CD12 trial. I am a doctor who is part of a large hospital network. In our state right now, the most recent statistics show that 67% of the patients in the ICU are on mechanical ventilation. That would place them in the critical category for the CD12 trial. This is an important statistic because we know that the mortality rate in this population was reported to be as high as 80% in the beginning of the pandemic and is probably still at least 35% or higher. If we assume that most or all of patients enrolled in CD12 came from the ICU you can apply the following math:
394 patients in trial
67% critical and 33% severe
394 x 0.667 = 262 critical patients
394 x .333 = 132 severe patients
Now, conservatively assume 40% mortality rate in critical and 15% in severe
262 Critical x 40% mortality rate = 105 expected deaths
132 Severe x 15% expected mortality rate = 20 expected deaths
Total deaths should have been 105 + 20 = 125 for a 31.7% death rate if Leronlimab did not work at all and placebo group was the same as treatment group. Instead, we saw 87 deaths. Assume 90 total since people may have died after we were told 87. That means we had 35 fewer deaths than expected.
The ratio of LL to placebo was 2:1 in the trial, so the number of people treated was 262. Expected deaths in the treatment group is 262 x .317 = 83. However, according to our calculations, we had 35 fewer deaths than expected. If this difference was all due to Leronlimab, the actual deaths in the treatment group were 83-35=48. That would leave 42 deaths in the placebo group. These number represent a statistically significant difference with p<0.05.
Since these are conservative estimates of mortality in each group, this is another indication that we will get very good results from CD12 IMO.
Thank You!
Can you explain? For some reason if I blow it up, becomes unreadable
I really could care less what your copy and paste says , READ THE HEADLINE!!
And...DEBUNKED and WHATABOUTTHAT??
Fuhgetaboutit
here ya go!
https://www.cytodyn.com/newsroom/press-releases/detail/271/cytodyn-reports-primary-endpoint-achieved-in-pro-140
Link to saying it never reached an endpoint?
Do you have any proof they did not reach endpoints?
Best news ever! Continued progress! Prayers for better health and returning home!!! Keep up the great support and strength!
Agreed, thank you for all your DD on CYDY. Owe you both a week of cocktails and dinners in Vegas!
Like it has been explained many times and for the 33rd time in the past hour, it needs to be analyzed and presented and will be announced the same day we uplist for some wow factor.
You left out this part:
The design of many clinical trials includes some strategy for early stopping if an interim analysis reveals large differences between treatment groups, or shows obvious futility such that there is no chance that continuing to the end,
And...wait for it-
Analysis time, what about that?
So, if you take a good look at how things are panning out this past week-
Uplisting is a done deal and well as EUA being put together for a double whammy HUGE fireworks PR
What I love the most is that, despite all the barking and yapping no critic here could invalidate my spreadsheet in my initial post.
Why? It's laughable and a waste of any smart investors time.
Tacit acceptance of my point that the company will not be able to uplist to NASDAQ.I'll place a bet that we uplist soon, taking the bet? And, as if by magic their independant posts claiming that the Fife debt conversion meant NASDAQ uplisting soon have disappeared completely. Tacit acceptance of my point again. LOL..right!
It’s game over guys. You got swindled by Wall Street financial engineering. The only finance pros (real senior pros I mean, not some CFA or CPA drone...) here are short.
Hey, questions for you. How much is CYDY up in the past year?
How many catalysts are in range?
Hw come the DSMC continued the trial TWICE without comment?
How come Leronlimab is widely available at request now?
Crickets...go back to the yahoo board
a nominal defendant means no responsibility, no fault and no right to recovery. Right? Thank you for the clarification that Cytodyn is not affected by the lawsuit.
So? Yawn
This will not affect their uplisting at all. As long as they are disclosed, no problem.
If the information provided warrants a further investigation, yes. DOJ may be the way to go. In 2018, Deputy Attorney General Rod Rosenstein announced the establishment of a new Task Force on Market Integrity and Consumer Fraud it provides guidance for the investigation and prosecution of crimes within financial markets, securities and commodities fraud, and other financial crimes. Looking at what evidence has been posted here, I'd bet there would be an investigation into the naked shorting of CYDY.
And don't forget they are "laughing"
Come on people, this is the ultimate setup for what's coming! Uplisting, EUA and OWS money!!!!
See you all in Vegas!
My accountant who's sitting right next to me just said and I quote " CYDY probably worked a deal with the financiers to file the S-3 as a requirement for uplisting and OWS money" . Huh, he may be right
JPG77...thats what I was referring to with the other PR. I wonder if they'll even announce it or does it just open on Nasdaq?
I'm laughing too! This was pre determined and nothing bad at all. I'll really be laughing at the next PR! Like rolling laughing. Those with doubts about Cytodyn are about to be schooled.
Interesting. There's been posts on other boards that members of this board have been in contact with an attorney regarding an investigation into the manipulation of CYDY. Can anyone confirm? If anyone knows this attorney, he or she would be the go to person.
Black-ops, nice.
Factual and to the point. CYDY is in a position to make history and I think will make headline news not only for the drugs success but also the ultimate short trap
How many lives did it save so far?You can get Leronlimab with a request, no?
So I'd venture to say it's doing excactly what it's supposed to do. SAVE LIVES
Don't blink, a one to punch is coming
two things-
FDA allowed the trial to be completed, no issues, no stoppage. DSMC found no issues and gave the nod to proceed.
Money? They are pre revenue. Don't forget though, inventory is paid for and ready to go. One click on the " buy now" tab and it becomes HUGE profit overnight.
I'd say we're there and ready to pounce. No?
And, I wonder if the term " pre revenue" comes to mind? Well, not for long
Amazing work, this is an incredible discovery. Have you sent this over to Nader and the team?
Huh, I wonder if the Wolfson family is in CYDY? I know a few of the sons extremely well, like "lets have cocktails"? well.
Totally agree! But, as we all know OWS is talking to Cytodyn and now with Dr. P's tweet this morning, it looks like all systems go.
I doubt Dr. P would tweet " post Leronlimab launch" if he was unsure. He wouldn't put his career on the line for a tweet. looks like a sweet PR coming soon!